PCNA in palate and tongue mucosal dysplastic lesions induced by topically applied 4NQO in desalivated rat;PCNA en lesiones displásicas de la mucosa de la lengua y del paladar inducidas por aplicación tópica de 4NQO en ratas desalivadas

Medicina Oral

Volumn 7, Issue 5, 2002, Pages 336-343

  Kaplan, Ilana ^a   Hochstadt, Tzachi ^a   Dayan, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

4NQO; Desalivation; Oral carcinogenesis; PCNA

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CARCINOGEN; CYCLINE; GLYCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DYSPLASIA; HYPERKERATOSIS; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; MORPHOMETRICS; MOUTH CANCER; MUCOSA; NONHUMAN; PALATE; PROTEIN EXPRESSION; RAT; SALIVA; SQUAMOUS CELL CARCINOMA; TONGUE; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; MALE; METABOLISM; MOUTH MUCOSA; PATHOLOGY; TOPICAL DRUG ADMINISTRATION; WISTAR RAT;

4-NITROQUINOLINE-1-OXIDE; ADMINISTRATION, TOPICAL; ANIMALS; CARCINOGENS; MALE; MOUTH MUCOSA; PALATE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; TONGUE;

EID: 0036846752     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Blanchaert RH. Epidemiology of oral cancer. In: Ord RA, Blanchaert RH, eds. Oral Cancer. Chicago: Quintessence Publishing Co, Inc: 2000. p. 3-8.
2. Binnie WH. Risk factors and risk markers for oral cancer in low incidence areas of the world. In: Johnson NW, ed. Oral Cancer. Cambridge: Cambridge University Press: 1991. p. 64-87.
3. Daftary DK, Murti PR, Bhonsle RB, Gupta PC, Mehta FS, Pindborg JJ. Risk factors and risk markers for oral cancer in high incidence areas of the world. In: Johnson NW. ed. Oral Cancer. Cambridge: Cambridge University Press: 1991. p. 29-63.
4. Eveson JW. Animal models of intra-oral chemical carcinogenesis: A review. J Oral Pathol 1981; 10: 129-46.
5. Steidler NE, Reade PC. Initiation and promotion of experimental oral mucosal carcinogenesis in mice. J Oral Pathol 1986; 15: 43-7.
6. Rich AM, Reade PC. Histomorphometric analysis of epithelial changes in chemically induced oral mucosal carcinogenesis in rats. J Oral Pathol 1988; 17: 528-33.
7. Fisker AV. Experimental oral carcinogenesis. A basic rat model for the study of oral carcinogenesis using the carcinogen 4-nitroquinoline 1-oxide. Dan Med Bull 1990; 37: 433-42.
8. Hawkins BL, Heniford BW, Ackermann DM, Leonberger M, Martinez SA, Hendler FJ. 4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma. Head Neck 1994; 16: 424-32.
9. Tanaka T, Kawamori T, Ohnishi M, Okamoto K, Mori H, Hara A. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res 1994; 54: 2359-65.
10. Kawabata K, Tanaka T, Honjo S, Kakumoto M, Hara A, Makita H, et al. Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis. Int J Cancer 1999; 83: 381-6.
11. Shklar G. Development of experimental oral carcinogenesis and its impact on current oral cancer research. J Dent Res 1999; 78: 1768-72.
12. Wallenius K, Lekholm U. Oral cancer in rats induced by the water soluble carcinogen 4-nitroquinoline-N-oxide. Odont Rev 1973; 24: 39-48.
13. Ohne M, Satoh T, Yamada S, Takai H. Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water. Oral Surg Oral Med Oral Pathol 1985; 59: 600-7.
14. Dayan D, Kaplan I, Russack S, Bodner L. Dysplastic changes of the palate and tongue mucosa induced by topically applied 4 nitro-quinoline-N-oxide (4NQO) in desalivated rats. In: Harris M, Johnson N, Varma AK, eds. Oral Oncology. Proceedings of the 5th International Congress on Oral Cancer. London: MacMillan India Ltd: 1997. p. 514-7.
15. Hay ID, Bowen WH. The functions of salivary proteins. In: Edgar WM, O'Mullane DM, eds. Saliva and Oral Health. London: British Dental Journal: 1996. p. 105-22.
16. Lekholm U, Wallenius K. Experimental oral cancer in rats with xerostomia. Odontol Revy 1976; 27: 11-8.
17. Dayan D, Hirshberg A, Kaplan I, Rotem N, Bodner L. Experimental tongue cancer in desalivated rats. Oral Oncol 1997; 33: 105-9.
18. Jenkins TD, Mueller A, Odze R, Shahsfaei A, Zukerberg LZ, Kent R, et al. Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium. Oncogene 1999; 18: 59-66.
19. Zhao JF, Zhang YJ, Jin XH, Athar M, Santella RM, Bicker DR, et al. Green tea protects against Psoralen plus ultraviolet A induced photochemical damage to skin. J Invest Derm 1999; 113: 1070-5.
20. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I, eds. Histological Typing of Cancer and Precancer of the Oral Mucosa. WHO. Berlin: Springer: 1997. p. 11-31.
21. Celis JE, Celis A. Cell cycle dependent variations in the distribution of the nuclear protein Cyclin Proliferating Cell Nuclear Antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci 1985; 82: 3262-6.
22. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM. Expression of Proliferating Cell Nuclear Antigen (PCNA) during the cell cycle. Exp Cell Res 1986; 166: 209-19.
23. Tan CK, Castilo C, So AG, Downey KM. An auxiliary protein for DNA polymerase delta from fetal calf thymus. J Biol Chem 1986; 26: 12310-6.
24. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, et al. Proliferating Cell Nuclear Antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasm. J Pathol 1990; 162: 285-94.
25. Landberg G, Roos G. Antibodies to Proliferating Cell Nuclear Antigen as S phase probes in flow cytometric cell cycle analysis. Cancer Res 1991; 51: 4570-4.
26. McCormick D, Hall PA. The complexities of Proliferating Cell Nuclear Antigen. Histopathology 1992; 21: 591-4.
27. Wilson GD, Camplejohn RS, Martindale CA, Brock A, Lane DP, Barnes DM. Flow cytometric characterisation of Proliferating Cell Nuclear Antigen using monoclonal antibody PC10. Eur J Cancer 1992; 28A: 2010-7.
28. Tsai ST, Jin YT, Proliferating Cell Nuclear Antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 1995; 24: 313-5.
29. Pindborg JJ, Reibel J, Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 1985; 14: 698-708.
30. Kaplan I, Engelberg J, Dayan D. The effect of desalivation on 4-nitroquinoline-1-oxide induced tongue carcinogenesis: A morphometric study of nucleolar organizer regions. J Oral Pathol Med 2001; 30: 48-51.